Pictured: Charles Sawyers
Honor
By Media Staff  |  Wednesday, February 20, 2013

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Pictured: Bernard Bochner
Video
By Memorial Sloan Kettering  |  Friday, January 11, 2013

Dr. Bochner – who specializes in treating people with prostate, bladder, and kidney cancers – discusses the importance of a multidisciplinary team approach to delivering high-quality care.

Pictured: Michael Zelefsky
In the Clinic
By Andrea Peirce, BA and Media Staff
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Pictured: PET Scan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 15, 2012

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Pictured: Charles Sawyers & Howard Scher
Announcement
By Memorial Sloan Kettering  |  Friday, August 31, 2012

Enzalutamide, a targeted therapy co-invented by a Memorial Sloan Kettering investigator, has received FDA approval for the treatment of men with metastatic prostate cancer.

Pictured: Karim Touijer
Video
By Memorial Sloan Kettering  |  Tuesday, July 31, 2012

Watch urologic surgeon Karim Touijer discuss our comprehensive approach to cancer care and recent advances in minimally invasive surgery.

Pictured: Howard Scher
Perspective
By Memorial Sloan Kettering  |  Friday, June 1, 2012

Memorial Sloan Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.

Pictured: Jonathan Coleman
Video
By Memorial Sloan Kettering  |  Monday, May 14, 2012

Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.

Pictured: James Eastham
Video
By Memorial Sloan Kettering  |  Monday, April 16, 2012

James Eastham, Chief of Memorial Sloan Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.

Pictured: American Association of Cancer Research Annual Meeting 2012
Announcement
By Media Staff  |  Tuesday, April 3, 2012

The American Association for Cancer Research (AACR), the world’s oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.

Pictured: Memorial Sloan Kettering logo
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators.

Pictured: Charles Sawyers & Howard Scher
In the News
By Media Staff  |  Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Pictured: Michael Quinlan
Patient Story
By Memorial Sloan Kettering  |  Thursday, January 19, 2012

When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.

Pictured: Michael Morris
In the Clinic
By Media Staff  |  Friday, January 13, 2012

Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.

Center News

Stay Informed

Get the latest information about cancer care and research every month.